Association of markers of inflammation on attention and neurobehavioral outcomes in survivors of childhood acute lymphoblastic leukemia

BackgroundSurvivors of childhood acute lymphoblastic leukemia (ALL) are at-risk of developing cognitive impairment and neurobehavioral symptoms. Inflammation induced by a compromised health status during cancer survivorship is proposed as a pathophysiological mechanism underlying cognitive impairmen...

Full description

Bibliographic Details
Main Authors: Yin Ting Cheung, Kenneth Kin-Wah To, Rong Hua, Chui Ping Lee, Agnes Sui-Ying Chan, Chi Kong Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1117096/full
_version_ 1797798482167201792
author Yin Ting Cheung
Kenneth Kin-Wah To
Rong Hua
Chui Ping Lee
Agnes Sui-Ying Chan
Chi Kong Li
Chi Kong Li
Chi Kong Li
author_facet Yin Ting Cheung
Kenneth Kin-Wah To
Rong Hua
Chui Ping Lee
Agnes Sui-Ying Chan
Chi Kong Li
Chi Kong Li
Chi Kong Li
author_sort Yin Ting Cheung
collection DOAJ
description BackgroundSurvivors of childhood acute lymphoblastic leukemia (ALL) are at-risk of developing cognitive impairment and neurobehavioral symptoms. Inflammation induced by a compromised health status during cancer survivorship is proposed as a pathophysiological mechanism underlying cognitive impairment in cancer survivors.ObjectivesTo evaluate the associations of biomarkers of inflammation with attention and neurobehavioral outcomes in survivors of childhood ALL, and to identify clinical factors associated with biomarkers of inflammation in this cohort.MethodsWe recruited patients who were diagnosed with ALL at ≤ 18 years old and were currently ≥5 years post-cancer diagnosis. The study outcomes were attention (Conners Continuous Performance Test) and self-reported behavioral symptoms (Adult Self-Report [ASR] checklist). Using a commercial screening kit, survivors’ plasma (5ml) was assayed for 17 cytokines/chemokine cell-signaling molecules that are associated with neurodegenerative diseases. The final panel of the targeted markers included interleukin (IL)-8, IL-13, interferon-gamma (IFN-γ), monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1β, and tumor necrosis factor-α. Biomarker levels were rank-ordered into tertiles based on the sample distribution. Multivariable general linear modeling was used to test for associations between biomarkers and study outcomes in the overall cohort and stratified by gender.ResultsThis study included 102 survivors (55.9% males, mean[SD] age 26.2[5.9] years; 19.3[7.1] years post-diagnosis). Survivors within top tertiles of IFN-γ (Estimate =6.74, SE=2.26; P=0.0037) and IL-13 (Estimate =5.10, SE=2.27; P=0.027) demonstrated more inattentiveness. Adjusting for age, gender and treatment, more self-reported thought (Estimate=3.53, SE=1.78; P=0.050) and internalizing problems (Estimate =6.52, SE=2.91; P=0.027) correlated with higher IL-8. Higher levels of IL-13 (RR = 4.58, 95% CI: 1.01–11.10) and TNF-α (RR = 1.44, 95% CI: 1.03–4.07) were observed in survivors had developed chronic health conditions (n=26, 25.5%). The stratified analysis showed that association of IFN-γ with attention was stronger in male survivors than in female survivors.ConclusionInflammation due to cancer-related late effects may potentially be mechanistic mediators of neurobehavioral problems in pediatric ALL survivors. Markers of inflammation can potentially be applied to assess or monitor the effectiveness of interventions, particularly behavioral interventions, in improving cognitive outcomes in survivors. Future work includes understanding the underlying gender-specific pathophysiology behind functional outcomes in the population.
first_indexed 2024-03-13T04:04:23Z
format Article
id doaj.art-8cdec53375444675bd0c2bff129b15da
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-13T04:04:23Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-8cdec53375444675bd0c2bff129b15da2023-06-21T09:11:34ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-06-011310.3389/fonc.2023.11170961117096Association of markers of inflammation on attention and neurobehavioral outcomes in survivors of childhood acute lymphoblastic leukemiaYin Ting Cheung0Kenneth Kin-Wah To1Rong Hua2Chui Ping Lee3Agnes Sui-Ying Chan4Chi Kong Li5Chi Kong Li6Chi Kong Li7School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, ChinaSchool of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, ChinaSchool of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, ChinaSchool of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, ChinaNeuropsychology Laboratory, Department of Psychology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, ChinaDepartment of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, ChinaDepartment of Paediatrics and Adolescent Medicine, Hong Kong Children’s Hospital, Hong Kong, Hong Kong SAR, ChinaHong Kong Hub of Paediatric Excellence, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, ChinaBackgroundSurvivors of childhood acute lymphoblastic leukemia (ALL) are at-risk of developing cognitive impairment and neurobehavioral symptoms. Inflammation induced by a compromised health status during cancer survivorship is proposed as a pathophysiological mechanism underlying cognitive impairment in cancer survivors.ObjectivesTo evaluate the associations of biomarkers of inflammation with attention and neurobehavioral outcomes in survivors of childhood ALL, and to identify clinical factors associated with biomarkers of inflammation in this cohort.MethodsWe recruited patients who were diagnosed with ALL at ≤ 18 years old and were currently ≥5 years post-cancer diagnosis. The study outcomes were attention (Conners Continuous Performance Test) and self-reported behavioral symptoms (Adult Self-Report [ASR] checklist). Using a commercial screening kit, survivors’ plasma (5ml) was assayed for 17 cytokines/chemokine cell-signaling molecules that are associated with neurodegenerative diseases. The final panel of the targeted markers included interleukin (IL)-8, IL-13, interferon-gamma (IFN-γ), monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1β, and tumor necrosis factor-α. Biomarker levels were rank-ordered into tertiles based on the sample distribution. Multivariable general linear modeling was used to test for associations between biomarkers and study outcomes in the overall cohort and stratified by gender.ResultsThis study included 102 survivors (55.9% males, mean[SD] age 26.2[5.9] years; 19.3[7.1] years post-diagnosis). Survivors within top tertiles of IFN-γ (Estimate =6.74, SE=2.26; P=0.0037) and IL-13 (Estimate =5.10, SE=2.27; P=0.027) demonstrated more inattentiveness. Adjusting for age, gender and treatment, more self-reported thought (Estimate=3.53, SE=1.78; P=0.050) and internalizing problems (Estimate =6.52, SE=2.91; P=0.027) correlated with higher IL-8. Higher levels of IL-13 (RR = 4.58, 95% CI: 1.01–11.10) and TNF-α (RR = 1.44, 95% CI: 1.03–4.07) were observed in survivors had developed chronic health conditions (n=26, 25.5%). The stratified analysis showed that association of IFN-γ with attention was stronger in male survivors than in female survivors.ConclusionInflammation due to cancer-related late effects may potentially be mechanistic mediators of neurobehavioral problems in pediatric ALL survivors. Markers of inflammation can potentially be applied to assess or monitor the effectiveness of interventions, particularly behavioral interventions, in improving cognitive outcomes in survivors. Future work includes understanding the underlying gender-specific pathophysiology behind functional outcomes in the population.https://www.frontiersin.org/articles/10.3389/fonc.2023.1117096/fullpediatric leukemiasurvivorscognitive functioninflammationlate effectspsychooncology
spellingShingle Yin Ting Cheung
Kenneth Kin-Wah To
Rong Hua
Chui Ping Lee
Agnes Sui-Ying Chan
Chi Kong Li
Chi Kong Li
Chi Kong Li
Association of markers of inflammation on attention and neurobehavioral outcomes in survivors of childhood acute lymphoblastic leukemia
Frontiers in Oncology
pediatric leukemia
survivors
cognitive function
inflammation
late effects
psychooncology
title Association of markers of inflammation on attention and neurobehavioral outcomes in survivors of childhood acute lymphoblastic leukemia
title_full Association of markers of inflammation on attention and neurobehavioral outcomes in survivors of childhood acute lymphoblastic leukemia
title_fullStr Association of markers of inflammation on attention and neurobehavioral outcomes in survivors of childhood acute lymphoblastic leukemia
title_full_unstemmed Association of markers of inflammation on attention and neurobehavioral outcomes in survivors of childhood acute lymphoblastic leukemia
title_short Association of markers of inflammation on attention and neurobehavioral outcomes in survivors of childhood acute lymphoblastic leukemia
title_sort association of markers of inflammation on attention and neurobehavioral outcomes in survivors of childhood acute lymphoblastic leukemia
topic pediatric leukemia
survivors
cognitive function
inflammation
late effects
psychooncology
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1117096/full
work_keys_str_mv AT yintingcheung associationofmarkersofinflammationonattentionandneurobehavioraloutcomesinsurvivorsofchildhoodacutelymphoblasticleukemia
AT kennethkinwahto associationofmarkersofinflammationonattentionandneurobehavioraloutcomesinsurvivorsofchildhoodacutelymphoblasticleukemia
AT ronghua associationofmarkersofinflammationonattentionandneurobehavioraloutcomesinsurvivorsofchildhoodacutelymphoblasticleukemia
AT chuipinglee associationofmarkersofinflammationonattentionandneurobehavioraloutcomesinsurvivorsofchildhoodacutelymphoblasticleukemia
AT agnessuiyingchan associationofmarkersofinflammationonattentionandneurobehavioraloutcomesinsurvivorsofchildhoodacutelymphoblasticleukemia
AT chikongli associationofmarkersofinflammationonattentionandneurobehavioraloutcomesinsurvivorsofchildhoodacutelymphoblasticleukemia
AT chikongli associationofmarkersofinflammationonattentionandneurobehavioraloutcomesinsurvivorsofchildhoodacutelymphoblasticleukemia
AT chikongli associationofmarkersofinflammationonattentionandneurobehavioraloutcomesinsurvivorsofchildhoodacutelymphoblasticleukemia